SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-003850
Filing Date
2021-01-13
Accepted
2021-01-13 16:01:43
Documents
15
Period of Report
2021-01-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm212959d1_8k.htm   iXBRL 8-K 37127
2 EXHIBIT 2.1 tm212959d1_ex2-1.htm EX-2.1 663547
3 EXHIBIT 10.1 tm212959d1_ex10-1.htm EX-10.1 20062
4 EXHIBIT 99.1 tm212959d1_ex99-1.htm EX-99.1 22187
  Complete submission text file 0001104659-21-003850.txt   1076016

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA cmrx-20210107.xsd EX-101.SCH 3187
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE cmrx-20210107_lab.xml EX-101.LAB 34592
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cmrx-20210107_pre.xml EX-101.PRE 22711
8 EXTRACTED XBRL INSTANCE DOCUMENT tm212959d1_8k_htm.xml XML 3606
Mailing Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713
Business Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713 919.806.1074
CHIMERIX INC (Filer) CIK: 0001117480 (see all company filings)

IRS No.: 330903395 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35867 | Film No.: 21526105
SIC: 2834 Pharmaceutical Preparations